Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Naveen Pemmaraju
Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Long-Term Follow-Up of Lower Dose Dasatinib (50 Mg Daily) as Frontline Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Cancer
Cancer Research
Oncology
FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Clinical Experience With the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies
American Journal of Hematology
Hematology
Prognostic Significance of Hyperdiploidy in Adult Acute Myeloid Leukemia
American Journal of Hematology
Hematology
Improving Outcomes for Patients With Acute Myeloid Leukemia in First Relapse: A Single Center Experience
American Journal of Hematology
Hematology
Prognostic Significance of Additional Chromosomal Abnormalities at the Time of Diagnosis in Patients With Chronic Myeloid Leukemia Treated With Frontline Tyrosine Kinase Inhibitors
American Journal of Hematology
Hematology
Acute Myeloid Leukemia With T(10;11): A Pathological Entity With Distinct Clinical Presentation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
1
2
›
